MEMO FROM THE FUTURE: VETERINARY INNOVATIVE FOUNDERS

The Opportunity Map for Building in Veterinary AI

Preface: This document is a speculative macro memo written from June 30, 2030, serving as a guide for entrepreneurs and founders considering starting companies in veterinary technology and AI. It maps the opportunity landscape, discusses market dynamics, outlines go-to-market strategies, and highlights common mistakes. It is a thought experiment, not a prediction, and should be read as rigorous fiction. This memo addresses venture capitalists, angel investors, and prospective founders interested in veterinary AI.

THE CONSEQUENCES OF ABUNDANT INTELLIGENCE: The Founder's Opportunity Map

Date: June 30, 2030

THE OPENING OPPORTUNITY

In 2026, the veterinary AI market barely existed. A founder interested in building in veterinary medicine faced long sales cycles, fragmented customers, and no clear defensible moat.

By mid-2030, the landscape has transformed. Venture capital deployed $1.4B into veterinary AI and technology from 2028-2029. The market is consolidating around clear platform winners, but gaps and niches still exist.

A founder with the right insight, timing, and execution can still build a $100M+ company in veterinary AI. But the window is narrowing. The path to success is radically different from even three years ago.

THE MARKET OVERVIEW

Market Size: - Total US veterinary market: $38.2B in 2029 - Companion animal (small animal): $28.4B (74% of market) - Large animal/equine: $5.9B (15%) - Aquaculture/exotic: $3.9B (11%)

The companion animal market is where the money is and where most startups should focus.

Market Structure: - Corporate-owned hospitals: 41% of market (but 59% of revenue, due to higher revenue per practice) - Independent practices: 41% of market, 30% of revenue - Academic/non-profit: 18% of market, 11% of revenue

Founder Strategy: Corporate groups are your beachhead. Land Mars, NVA, or Pathway as a customer, and you can scale rapidly through them. Independents are harder to sell to but have higher pain points (they're less efficient, less profitable). Non-profits have low budgets.

THE OPPORTUNITY MAP

Tier 1: AI Diagnostic Platforms (Highest difficulty, highest value)

These are the platforms that interpret imaging (X-ray, ultrasound), pathology, blood work, and other diagnostics.

Market Potential: $1.8B+ by 2035 (vs. $280M in 2029)

Why it's attractive: These are mission-critical tools. Every vet needs them. They command high prices ($40-80K/year per practice).

Why it's hard: - Requires massive training datasets (millions of high-quality labeled cases) - Regulatory/liability concerns (practices are liable if AI misinterprets) - IDEXX and Mars have 70%+ of the data - Requires domain expertise (veterinary pathology knowledge) + ML skills - Clinical validation is slow and expensive

Key insight: You don't need to build a general diagnostic AI. You can specialize in a specific domain (orthopedic imaging, ultrasound, dermatopathology, ophthalmology) and become the best in that domain. A specialized AI that's 2-3% better than general systems can command a premium.

Current players: Mars AI (dominant), IDEXX's new platform, Zoetis, emerging startups (VetAI Labs, eVetDiagnostics)

Go-to-market: Land a corporate group first (they buy at scale), then build for independents. Regulatory advantage: no FDA approval needed (huge advantage over human medical AI).

Tier 2: Telemedicine and Virtual Care (High difficulty, high value, growing fast)

Telemedicine for pets is growing 340%+ annually (2028-2029). The market is still early but consolidating around a few platforms.

Market Potential: $2.1B by 2035 (vs. $920M in 2029)

Why it's attractive: - Massive total addressable market (millions of pet owners want convenient care) - Pet owners are willing to pay premium prices for convenience - Less capital-intensive than building physical practices - Can monetize multiple ways: subscription, per-call, partnerships with insurers

Why it's hard: - Regulatory varies by state (licensing requirements for vets) - Network effects matter (more vets → more available appointments → more customers) - Customer acquisition cost is high (need to market to millions of pet owners) - Vet retention is challenging (vets can work through multiple platforms)

Key insight: The winners will own the vet supply side and the pet owner demand side. Be a platform that attracts both. Differentiate on UX (both vet and owner sides), speed of care, and clinical quality.

Current players: Vetster (dominant), Ask My Vet, PetCare, Vetly (emerging)

Go-to-market: B2C (direct to pet owners via app store) or B2B (partner with pet insurance, veterinary clinics). B2C is harder but has higher margins. B2B is faster but you're dependent on partners.

Tier 3: Smart Practice Management (Medium difficulty, high value, consolidating)

The "veterinary operating system" that integrates all aspects of practice management with AI.

Market Potential: $1.2B by 2035 (vs. $400M in current standalone software)

Why it's attractive: - Every practice needs this (even more critical as practices consolidate) - Sticky (switching costs are high once you've adopted) - Recurring revenue (SaaS model) - Data network effects (more practices on your system = better AI)

Why it's hard: - IDEXX, Mars, and Covetrus are heavily investing - Massive feature parity required (you need medical records, scheduling, billing, client portal, analytics, diagnostics, imaging, AI — everything) - Integration requirements (must work with existing equipment, analyzers, imaging systems) - Sales cycles are long (9-18 months to land a practice)

Key insight: You're not going to beat IDEXX or Covetrus on breadth. But you can win on: - Specialty focus — Build the best PM system for surgeons, dentists, exoticists, or behavioral vets. Specialize deeply. - Ease of use — Build something so much better to use that practices are willing to migrate despite switching costs. - Cost — Some practices will switch for 30-40% lower cost, especially if you cut features they don't need. - Speed — Build something that makes practices more efficient (scheduling, diagnostics integration, charting automation). ROI sells.

Current players: IDEXX Neo, Covetrus Pulse, Cornerstone, Shepherd, Vetly (emerging, AI-native)

Go-to-market: Focus on specialists or specific geographies. Build deep relationships with practice consultants and veterinary advisors (they influence software selection). Partner with corporate groups to test and refine.

Tier 4: AI Pet Health Monitoring and Wearables (Medium difficulty, medium-high value, early stage)

Wearables and AI systems that monitor pet health in real-time, predict disease, and recommend preventive care.

Market Potential: $1.4B by 2035 (vs. $180M in 2029)

Why it's attractive: - Pet owners spend irrationally on their pets (willing to pay for convenience and health) - Large TAM (millions of pet owners with multiple pets) - Multiple revenue streams: hardware, subscription, data licensing to insurers - Less competition than diagnostics or telemedicine

Why it's hard: - Hardware manufacturing is capital-intensive and logistically complex - Requires regulatory clearance (FDA, FCC for wireless devices) - Building a vet integration layer is non-trivial - Data privacy and security are critical (hacking = liability)

Key insight: The winners will be companies that: - Build hardware that's actually useful (not just a Fitbit for pets) - Integrate deeply with veterinary practices (so the data flows to vets, not just to owners) - Use AI to generate actionable insights (not just data) - Have a clear monetization path with veterinarians and/or insurers

Current players: FitBark (early stage), Whistle (acquired by Mars), emerging startups

Go-to-market: Start with a strong consumer product (get pet owners buying), then build the veterinary integration. Or start with veterinary practices and work backward to consumers.

Tier 5: AI Veterinary Talent and Training Platforms (Lower difficulty, medium value, emerging)

Platforms for recruiting, training, mentoring, and managing veterinary talent using AI.

Market Potential: $380M by 2035 (vs. $80M in 2029)

Why it's attractive: - There's a real talent shortage - Veterinary practices have massive inefficiencies in how they recruit and train - AI can help match candidates to roles, optimize team structure, predict burnout - High gross margins for software

Why it's hard: - Smaller total market than diagnostics or telemedicine - Requires understanding veterinary-specific talent dynamics - Practices are conservative about HR/organizational changes

Key insight: Build a platform that helps independent practices and small groups compete with corporate groups on talent. If you can help a 3-vet practice attract and retain good talent, they'll pay for it.

Current players: Veterinary staffing agencies (traditional, not AI-native), LinkedIn (generic), emerging startups

Go-to-market: Target practice consultants and group owners (they make talent decisions). Offer data and analytics on veterinary talent market.

Tier 6: AI-Optimized Pet Insurance (Lower difficulty, medium value, consolidating)

Insurance companies using AI to price risk, deny claims, and optimize profitability.

Market Potential: $2.8B by 2035 (vs. $1.8B in 2029)

Why it's attractive: - Insurance market is growing (pet insurance adoption up 12% annually) - AI can improve profitability significantly - Network effects (more customers = more data = better risk models)

Why it's hard: - Requires massive customer base to be viable (underwriting risk) - Regulatory constraints (insurance is heavily regulated) - Customer acquisition cost is high (marketing to pet owners) - Established players (Nationwide, Trupanion, Lemonade pet) have scale advantages

Key insight: Don't try to be a full insurance company. Partner with existing insurers or be a specialized player: - Insure specific segments (exotic animals, pure breed dogs, geriatric pets) - Insure specific conditions (pet dental, wellness-only, accident-only) - Offer embedded insurance (integrate into veterinary practices or pet health platforms)

Current players: Trupanion, Nationwide Pet, Lemonade Pet, emerging startups

Go-to-market: Partner with veterinary practices or telemedicine platforms to distribute embedded insurance.

Tier 7: Veterinary Data Analytics and Market Intelligence (Lower difficulty, medium value, emerging)

Platforms that aggregate veterinary market data, provide benchmarking, competitive intelligence, and predictive analytics to practices and industry players.

Market Potential: $240M by 2035 (vs. $30M in 2029)

Why it's attractive: - Low-friction business (data is valuable, pricing is based on value) - Can monetize multiple ways (subscription, API licensing, custom analytics) - Network effects (more practices on your platform = more valuable data) - Emerging as a critical need as consolidation accelerates

Why it's hard: - Requires access to practice data (which is fragmented and private) - Practices are conservative about sharing data - Regulatory concerns around data privacy

Key insight: Start with a specific angle: - Revenue benchmarking for practices (help owners understand if they're profitable) - Market intelligence for corporate groups (help them identify acquisition targets) - Competitive analysis (help practices understand their competitive landscape) - AI-powered clinical insights (aggregate outcome data to improve protocols)

Current players: Veterinary economics research firms (non-AI), emerging startups

Go-to-market: Partner with practice consultants, veterinary associations, and corporate groups.

Tier 8: Specialized/Vertical Solutions (Lower difficulty, medium value, fragmented)

AI solutions for specific veterinary specialties or use cases: - AI for dental practices (imaging, diagnosis, treatment planning) - AI for orthopedic surgery (imaging, surgical planning) - AI for behavioral/fear-free medicine - AI for large animal/equine medicine - AI for exotic animal medicine - AI for end-of-life/hospice care

Market Potential: $600M+ by 2035 (aggregate across all specialties, vs. $120M in 2029)

Why it's attractive: - Lower competition (each specialty is small enough that most platforms ignore it) - High willingness to pay (specialists have higher margins and specific pain points) - Easier to become the dominant player in a narrow segment

Why it's hard: - Smaller total market per specialty - Requires deep domain expertise (understanding specialty workflows) - Challenging to build a sustainable business in a small segment

Key insight: Pick a specialty where: 1. Practices have clear pain points (inefficiency, diagnostic complexity) 2. There's little existing AI competition 3. Specialists have high margins and willingness to pay 4. You have personal expertise or strong advisory network in that specialty

Current players: Mostly empty niches (large opportunity)

Go-to-market: Become the expert in your specialty. Publish research, speak at conferences, build relationships with thought leaders.

THE DEFENSIBLE MOAT HIERARCHY

Not all AI companies can build defensible moats. Here's the hierarchy:

Highest Moat (hardest to disrupt): - Data network effects (more practices using your system = more data = better AI = more practices want to use it) - Integration/switching costs (your system is deeply integrated with their operations) - Clinical validation (third-party studies proving your AI works)

Medium Moat: - Brand and reputation (vets know your company and trust it) - Partnerships and integrations (your platform works with everything) - Specialized expertise (you're the best in a specific domain)

Lowest Moat (easy to disrupt): - Being first (first-mover advantage is minimal in B2B software) - Cheap (competitors can match your price) - Nice-to-have features (practices can live without it)

Build for moat. Don't build something that a competitor can replicate in 18 months.

GO-TO-MARKET STRATEGY FOR VETERINARY STARTUPS

Phase 1: Beachhead (Years 1-2)

Pick a specific customer segment and dominate it. Don't try to serve everyone.

Options: - Corporate group focus: Land one of the Big Three (Mars, NVA, Pathway) as a customer. Use them to refine product and generate case studies. Land their competitors. - Geographic focus: Pick a region (California, Texas, Northeast) and dominate it. Deep relationships, local presence, personalized service. - Specialty focus: Dominate surgeons, dentists, exotic vets, or another specialty. Be the expert. - Use case focus: Own a specific problem (diagnostic accuracy, scheduling optimization, client communication).

Phase 2: Land and Expand (Years 2-4)

Once you've proven product-market fit in your beachhead: - Build on the success stories (case studies, ROI validation, clinical evidence) - Expand to adjacent segments - Scale sales (hire sales team, build partnerships) - Raise Series A/B funding

Phase 3: Scale (Years 4+)

Scale the go-to-market: - National/international expansion - Product expansion (add features, integrations) - M&A (acquire competitors or complementary companies) - IPO or acquisition

COMMON MISTAKES FOUNDER MAKE

Mistake 1: Building for Vets Instead of for Practice Economics

Vets care about clinical quality and ease of use. Practice owners care about profitability and efficiency.

If you're selling to practice owners, build for their economics. If you're selling to vets, build for their clinical needs. Don't confuse the two.

Mistake 2: Underestimating Corporate Group Procurement Cycles

You think it'll take 3 months to close a deal with a corporate group. It takes 12-18 months.

Corporate groups have: - Multiple stakeholders (medical director, CFO, CTO, operations) - Rigorous evaluation processes - Regulatory/compliance concerns - Change management challenges

Budget accordingly. Raise capital assuming 18-month sales cycles for corporate customers.

Mistake 3: Ignoring the Emotional Dimension of Vet Care

Veterinary medicine isn't just about clinical outcomes. It's about the emotional bond between vet and pet owner, between vet and pet, between practice and community.

AI that improves outcomes but disrupts relationships won't be adopted, even if it makes financial sense.

The best veterinary AI products enhance relationships, don't replace them. They give vets more time for what they actually care about (caring for animals, supporting owners).

Build with this in mind.

Mistake 4: Not Understanding Regional Variation

The US is not one market. UK is different from Australia is different from Canada.

• UK: RCVS regulation is stronger, consolidation is further along, telemedicine adoption is higher
• Australia: Rural vet shortage is acute, practices are more geographically dispersed, telemedicine opportunity is huge
• Canada: Provincial regulation fragments the market, adoption is slower than US

Don't assume US dynamics apply everywhere.

Mistake 5: Building Before Validating

Talk to 50 vets and practice owners before writing a line of code.

Understand the real problem (not the problem you think they have). Build the solution to that problem.

Mistake 6: Missing the Data Story

Data is the long-term moat. If your product doesn't generate data, or doesn't get better with more data, you're not defensible.

Build with data/network effects in mind from day one.

THE FUNDING LANDSCAPE

Capital Available: - Venture capital focused on veterinary AI: ~$1.4B deployed in 2028-2029 - Angel capital: Strong, especially from founders and operators in adjacent markets (human health, agriculture tech) - Strategic capital: Corporate groups (Mars, NVA, VCA) are investing/acquiring - Later-stage capital: Available for proven models

Funding Trajectory (typical for a successful veterinary AI startup):

Investors to Know: - Specialized vet tech VCs: Collaborative Fund, Fifty Years VC (now Point Horizon), Altos Ventures - Pet/consumer VCs: Baseline, Benchmark, Khosla Ventures (have made vet bets) - Deep tech VCs: Lowercarbon, Maven (AI focused) - Strategic/Corporate capital: Mars Ventures, NVA (through PE parent), VCA (acquired, but other corporates are investing)

THE PATH TO $100M+ VALUATION

To build a $100M+ company in veterinary AI, you need:

1. A Large Market — TAM of at least $500M+ (telemedicine, diagnostics, practice management, pet health monitoring qualify; niche specialties don't)

2. Product-Market Fit — NPS of 50+, retention of 90%+, growth rate of 20%+ MoM in early years

3. Defensible Moat — Data network effects, switching costs, specialized expertise, or integration depth

4. Clear Monetization — SaaS (recurring revenue), licensing, data licensing, or hardware + service model

5. Founding Team — CEO with 10+ years experience (ideally in adjacent markets), CTO with strong AI/ML credentials, and one veterinary expert (founder, advisor, or early hire)

6. Right Timing — The market needs to be ready to adopt your solution (2029-2030 market is ready for most categories)

CLOSING: THE FOUNDER'S MOMENT

It's June 30, 2030. The veterinary AI market has moved from early-stage to growth-stage. The window for early-stage founders is closing, but it's not closed.

The companies that will win in the next 5 years are being started now. They're not going to be founded by the same people who founded Vetster or IDEXX's AI division. They're going to be founded by ambitious founders who understand both veterinary medicine and AI, who pick a specific problem to solve, and who execute relentlessly.

The opportunities are real. The capital is available. The market is ready.

The question is: Are you going to be one of the founders who builds the next generation of veterinary AI companies?

If you are, here's your path: 1. Pick your specific opportunity (from the opportunities above, or an adjacent one) 2. Validate the problem with 50+ conversations with potential customers 3. Build a product that solves the problem better than anything else 4. Get your first 10-20 paying customers and obsess over retention 5. Raise capital from investors who understand the space 6. Scale

The founders who execute this path will build the $1B+ veterinary AI companies of the 2030s.

The question is: Are you going to be one of them?